Piramal Pharma Limited

PPLPHARMA

Promoter
34.80%
Free float
37.11%
Institutions & govt
28.09%
Promoter pledged
—

The register over time

Drawing the chart…

Worth knowing

  • The row marked Non-promoter, non-public is a third table: shares that belong to neither the promoter nor the public, so they are in neither of the two figures a reader is comparing. 216 of the 2,914 companies we hold a shareholding filing for report a holding in it, and in every one of them it is a trust holding shares for employees; the other line it can carry, shares left with a depository-receipt custodian, is reported by two companies and both of those report 0.00%. Counted 11 November 2026.

The split now

As of 30 Sept 2026

Drawing the chart…

Shareholding by category

  • Public

    64.80%

    4,13,177 holders

  • Non-institutions

    36.71%

    4,12,911 holders

  • Institutions - domestic

    14.44%

    73 holders

  • Institutions - foreign

    13.65%

    191 holders

  • Government

    0.00%

    2 holders

  • Promoter & promoter group

    34.80%

    17 holders

  • Indian promoters

    34.80%

    17 holders

  • Non-promoter, non-public

    —

    3 holders

  • Employee benefit trusts

    0.40%

    3 holders

  • Foreign companies

    17.93%

    1 holders

  • Foreign nationals

    0.06%

    12 holders

Public
64.80%
Non-institutions
36.71%
Institutions - domestic
14.44%
Institutions - foreign
13.65%
Government
0.00%
Promoter & promoter group
34.80%
Indian promoters
34.80%
Non-promoter, non-public
—
Employee benefit trusts
0.40%
Foreign companies
17.93%
Foreign nationals
0.06%

Who runs it

Board of directors10
of which: women3
Women's share of the board30.00%
Key management personnel4
of which: women2
Employees who left during the year23.00%
VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.